Capital Fund Management S.A. Invitae Corp Transaction History

Capital Fund Management S.A.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$24.31 - $33.6 $1.69 Million - $2.34 Million	-69,593 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$26.09 - $40.4 $1.82 Million - $2.81 Million	69,593 New	69,593 $2.35 Million
Q1 2020 May 13, 2020	SELL	$7.64 - $27.5 $186,209 - $670,257	-24,373 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$15.02 - $20.57 $9,702 - $13,288	-646 Reduced 2.58%	24,373 $393,000
Q3 2019 Nov 13, 2019	BUY	$18.85 - $27.5 $252,948 - $369,022	13,419 Added 115.68%	25,019 $482,000
Q4 2018 Feb 13, 2019	BUY	$9.26 - $16.38 $107,416 - $190,008	11,600 New	11,600 $128,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.